Abstract
Heart failure is one of the leading healthcare problems in the world. Clinical data lacks sensitivity and specificity in the diagnosis of heart failure. Laboratory biomarkers are a non-inva-sive method of assessing suspected decompensated heart failure. Biomarkers such as natriuretic peptides have shown promising results in the management of heart failure. The literature does not provide comprehensive guidance in the utilization of biomarkers in the setting of acute heart failure syndrome. Many conditions that manifest with similar pathophysiology as acute heart failure syndrome may demonstrate positive biomarkers. The following is a review of biomarkers in heart fail-ure, enlightening their role in diagnosis, prognosis and management of heart failure.
| Original language | English |
|---|---|
| Article number | e090921196330 |
| Pages (from-to) | 35-45 |
| Number of pages | 11 |
| Journal | Current Cardiology Reviews |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2022 |
| Externally published | Yes |
Keywords
- Acute heart failure syndrome
- biomarkers
- diagnosis
- follow up
- heart failure
- risk stratification
Fingerprint
Dive into the research topics of 'Biomarkers in Acute Heart Failure Syndromes: An Update'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver